Pharmaceutical Industry

Is the
current model fit for purpose?

These are symptoms of a decline of the pre-digital era model of medicinal product development. Our pharmaceutical industry members are those who are committed to moderninsing their product development to create safer and more effective medicinal products. 

Modernisation of the pharmaceutical industry requires a coresponding moderninsation of the way in which medicinal products are brought on to the market and the design of clinical trials. The Avicenna Alliance is working to promote modelling and simulation as a means of addressing the high cost of research and the uptake of in silico methods.

Avicenna Alliance news

The European Commission has established the European Health and Digital Executive Agency (HaDEA)

On 1 April, the European Commission has newly established the European Health and Digital Executive...

find out more ›

President Biden’s plans to establish HARPA

U.S. President Joe Biden is considering plans to create an Advanced Research Projects Agency for Health (HARPA). This entity would support the funding of...

find out more ›

Avicenna provides input to the European Parliament Special Committee on Beating Cancer

Early March, the Avicenna Alliance had the opportunity to provide the European Parliament’s Committee on...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up